These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
11-3027591
|
|
(State or Other Jurisdiction
|
|
(IRS Employer
|
|
of Incorporation or Organization)
|
|
Identification Number)
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock $.01 par value
|
|
NYSE American
|
|
|
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Non-accelerated filer ☐
|
Smaller Reporting Company ☒
|
|
Emerging growth company ☐
|
|
PART I
|
||
|
Item 1.
|
Business
|
1
|
|
Item 1A.
|
Risk Factors
|
16
|
|
Item 1B.
|
Unresolved Staff Comments
|
27
|
|
Item 2.
|
Properties
|
27
|
|
Item 3.
|
Legal Proceedings
|
27
|
|
Item 4.
|
Mine Safety Disclosures
|
30
|
|
PART II
|
||
|
Item 5.
|
Market For Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
31
|
|
Item 6.
|
Selected Financial Data
|
33
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operation
|
33
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
40
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
40
|
|
Item 9.
|
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
|
40
|
|
Item 9A.
|
Controls and Procedures
|
40
|
|
Item 9B.
|
Other Information
|
41
|
|
PART III
|
||
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
42
|
|
Item 11.
|
Executive Compensation
|
46
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
51
|
|
Item 13.
|
Certain Relationships and Related Transactions and Director Independence
|
53
|
|
Item 14.
|
Principal Accounting Fees and Services
|
54
|
|
PART IV
|
||
|
Item 15.
|
Exhibits and Financial Statement Schedules
|
55
|
|
Signatures
|
57
|
|
●
|
Cisco Systems, Inc.*
|
●
|
Motorola Solutions, Inc.*
|
|
●
|
Microsemi Corporation*
|
●
|
NEC Corporation*
|
|
●
|
Dell, Inc.*
|
●
|
Polycom, Inc.*
|
|
●
|
Extreme Networks, Inc.*
|
●
|
Adtran, Inc.
|
|
●
|
Samsung Electronics Co., Ltd
|
●
|
Huawei Technologies Co., Ltd.
|
|
●
|
Netgear, Inc.*
|
●
|
Allied Telesis, Inc.*
|
|
●
|
Transition Networks, Inc.*
|
●
|
Enterasys Networks, Inc.
|
|
●
|
GarrettCom,Inc.*
|
●
|
Foundry Networks, Inc.
|
|
●
|
Shoretel,Inc.*
|
●
|
SEH Technology, Inc.*
|
|
●
|
D-Link Corporation and D-Link Systems, Inc.*
|
●
|
Buffalo Technology (USA), Inc.*
|
|
●
|
BRG Precision Products, Inc.*
|
●
|
Sony Corporation
|
|
●
|
Alcatel-Lucent USA/Alcatel-Lucent Holdings, Inc. |
●
|
ALE USA Inc.
|
|
●
|
Axis Communications, Inc. |
●
|
Avaya, Inc.*
|
|
●
|
Juniper Networks, Inc. |
|
·
|
our ability to overturn on appeal to the Federal Circuit the District Court order of non-infringement related to the HP Jury Verdict;
|
|
·
|
the outcome of our other legal proceedings;
|
|
·
|
our ability to receive future material revenue from licensees of our Remote Power Patent;
|
|
·
|
our ability to license and monetize our Cox Patent Portfolio;
|
|
·
|
our ability to overturn on appeal to the Federal Circuit the District Court order granting summary judgment and dismissing our litigation against Facebook involving certain of our Mirror Worlds patents;
|
|
·
|
our ability to further license and monetize our Mirror Worlds Patent Portfolio;
|
|
·
|
our ability to further develop, license and monetize our M2M/IoT Patent Portfolio;
|
|
·
|
our ability to acquire additional intellectual property;
|
|
·
|
our ability to continue to achieve material revenue and profits;
|
|
·
|
our ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property;
|
|
·
|
our ability to achieve a return on our investment in ILiAD Biotechnologies, LLC;
|
|
·
|
variations in our quarterly and annual operating results;
|
|
·
|
our ability to raise capital if needed;
|
|
·
|
sales of our common stock;
|
|
·
|
technology changes;
|
|
·
|
legislative, regulatory and competitive developments; and
|
|
·
|
economic and other external factors.
|
|
ITEM 5.
|
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
|
Period
|
Total Number of
Shares Purchased
|
Average Price
Paid Per Share
|
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
|
Maximum Number
(or Approximate
Dollar Value) of
Shares) that May
Yet Be Purchased
Under the Plans
or Programs
|
|
October 1, 2018 to
October 31, 2018 |
—
|
—
|
—
|
$ 1,394,532
|
|
November 1, 2018 to
November 30, 2018
|
9,594
|
$2.56
|
9,594
|
$ 1,369,935
|
|
December 1, 2018 to
December 31, 2018
|
20,900
|
$2.30
|
20,900
|
$ 1,321,767
|
|
Total
|
30,494
|
$2.39
|
30,494
|
—
|
|
(a)
Number of
securities to be
issued upon
exercise of
outstanding
options and rights
|
Weighted-
average
exercise price of outstanding
options and
rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column)(a) | ||||||||||
|
Equity compensation plans approved by security holders
|
890,000
|
(1)
|
$
|
1.84
|
(3)
|
1,267,197
|
||||||
|
Equity compensation plans not approved by security holders
|
1,250,000
|
(2)
|
$
|
0.97
|
—
|
|||||||
|
Total
|
2,140,000
|
$
|
1.18
|
(3)
|
1,267,197
|
|||||||
|
(1)
Includes 385,000 shares of our common stock issuable upon exercise of outstanding stock options and 505,000 shares issuable upon vesting of outstanding restricted stock units.
(2)
Represents aggregate individual option grants outside of, and prior to the establishment of, the 2013 Stock Incentive Plan in October 2013 referred to in the above table which represents individual option grants issued to our officers, directors, employees and consultants in consideration for certain services rendered to us. The option agreements pertaining to such individual option grants contain customary anti-dilution provisions.
(3)
Does not take into account outstanding restricted stock units as these awards have no exercise price.
|
|
NAME
|
AGE
|
POSITION
|
||
|
Corey M. Horowitz
|
64
|
Chairman, Chief Executive Officer and Chairman of the Board of Directors
|
||
|
David C. Kahn
|
67
|
Chief Financial Officer, Secretary and a Director
|
||
|
Jonathan Greene
|
57
|
Executive Vice President
|
||
|
Emanuel Pearlman
|
59
|
Director
|
||
|
Niv Harizman
|
54
|
Director
|
||
|
Allison Hoffman
|
48
|
Director
|
|
Name and
Principal Position |
Year
|
Salary ($)
|
Bonus ($)
|
Stock
Awards($) (3) |
All Other
Compensation($) (1) |
Total($)
|
||||||||||||||||
|
Corey M. Horowitz
|
2018
|
$
|
497,000
|
$
|
1,281,000
|
(2)
|
$
|
—
|
$
|
92,750
|
(4)
|
$
|
1,870,750
|
|||||||||
|
Chairman and Chief Executive Officer
|
2017
|
$
|
482,000
|
$
|
998,000
|
(2)
|
$
|
—
|
$
|
36,000
|
(4)
|
$
|
1,516,000
|
|||||||||
|
David C. Kahn
|
2018
|
$
|
175,000
|
$
|
30,000
|
$
|
102,400
|
(3)
|
$
|
40,250
|
(5)
|
$
|
347,650
|
|||||||||
|
Chief Financial Officer
|
2017
|
$
|
1
75
,000
|
$
|
30,000
|
$
|
—
|
$
|
37,250
|
(5)
|
$
|
242,250
|
||||||||||
|
Jonathan Greene
|
2018
|
$
|
200,000
|
$
|
40,000
|
$
|
128,000
|
(3)
|
$
|
40,250
|
(6)
|
$
|
408,250
|
|||||||||
|
Executive Vice President
|
2017
|
$
|
200,000
|
$
|
40,000
|
$
|
—
|
$
|
37,250
|
(6)
|
$
|
277,250
|
||||||||||
|
(1)
|
We have concluded that the aggregate amount of perquisites and other personal benefits paid in 2018 and 2017 to either Mr. Horowitz, Mr. Kahn or Mr. Greene did not exceed $1
0,000.
|
|
(2)
|
Mr. Horowitz received the following cash incentive bonus payments for 2018: (i) an annual discretionary bonus of $175,000
and (ii) incentive bonus compensation of $1,106,000 pursuant to his employment agreement (see "Employment Agreements-Termination of Employment and Change In-Control Arrangements" below). Mr. Horowitz received the following cash incentive bonus payments for 2017: (i) an annual discretionary bonus of $175,
000
and (ii) incentive bonus compensation of $823,000
pursuant to his employment agreement.
|
|
(3)
|
The amounts in this column represent the aggregate grant date fair value of restricted stock units awards granted to the Named Executive Officers computed in accordance with FASB ASC Topic 718. In accordance with SEC rules, the grant date fair value of an award that is subject to a performance condition is based on the probable outcome of the performance condition. See Note F[1] to our consolidated financial statements included in this Annual Report for a discussion of the assumptions made by the Company in determining the grant date fair value.
|
|
(4)
|
Includes 401K matching funds contributions by the Company and profit sharing under the Company's 401k Plan for the benefit of Mr. Horowitz of $36,500
for 2018 and $36,000 for 2017, respectively. Also includes payment of dividends (dividend equivalent rights) on restricted stock units owned by Mr. Horowitz for 2018 of $56,250.
|
|
(5)
|
Includes 401K matching funds contributions by the Company and profit sharing under the Company's 401k Plan for the benefit of Mr. Kahn of $36,500 for 2018 and $36,000 for 2017
.
Also includes payment of dividends (dividend equivalent rights) on restricted stock units owned by Mr. Kahn for 2018 and 2017 of $3,750 and $1,250, respectively.
|
|
(6)
|
Represents 401K matching funds contributions by the Company and profit sharing under the Company's 401k Plan for the benefit of Mr
.
Greene of $36,500 for 2018 and $36,000 for 2017
.
Also includes payment of dividends (dividend equivalent rights) on restricted stock units owned by Mr. Greene for 2018 and 2017 of $3,750 and $1,250, respectively.
|
|
Name
|
Fees earned or paid in cash ($)
(1)
|
Stock Awards
($)
(2) (3)
|
All other compensation ($)
(4)
|
Total
($)
|
||||||||||||
|
Emanuel Pearlman
|
$
|
50,000
|
$
|
39,638
|
$
|
625
|
$
|
90,263
|
||||||||
|
Niv Harizman
|
$
|
46,250
|
$
|
39,638
|
$
|
625
|
$
|
86,513
|
||||||||
|
Allison Hoffman
|
$
|
48,830
|
$
|
39,638
|
$
|
625
|
$
|
89,093
|
||||||||
|
(1)
|
Represents director's fees payable in cash to each non-management director of $10,000 per quarter ($40,000 per annum) for 2018 plus additional cash fees for serving on Board committees as disclosed in the text above.
|
|
(2)
|
The amounts included in this column represent the grant date fair value of restricted stock unit awards (RSUs) granted to directors, computed in accordance with FASB ASC Topic 718. For a discussion of valuation assumptions see Note F[1]
to our consolidated financial statements included in this Annual Report. The 15,000 RSUs granted to each non-management director vested on a quarterly basis beginning March 15, 2018. Each restricted stock unit represents the contingent right to receive one share of common stock.
|
|
(3)
|
As of December 31, 2018, each of the above listed directors held outstanding stock options to purchase 70,000 shares of our common stock.
|
|
(4)
|
Includes payment of dividends (dividend equivalent rights) on RSUs for 2018.
|
|
Option Awards
|
Stock Awards
|
|||||||||||
|
Name
|
Number of Securities
Underlying Unexercised Options |
Option Exercise Price ($)
|
Option
Expiration
Date
|
Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested
|
Equity incentive plan awards: Market value of unearned shares, units or other rights that have not vested(1) ($)
|
|||||||
|
Exercisable
|
Unexercisable
|
|||||||||||
|
Corey M. Horowitz
Chairman and CEO
|
500,000
750,000
|
—
—
|
$ 1.19
$ 0.83
|
11/01/22
6/08/19
|
375,000(2)
|
$836,250
|
||||||
|
David Kahn
Chief Financial Officer
|
50,000
|
—
|
$ 1.65
|
4/09/19
|
40,000(3)
|
$ 89,200
|
||||||
|
Jonathan Greene
Executive Vice President
|
50,000
|
—
|
$ 1.65
|
4/09/19
|
50,000(4)
|
$111,500
|
||||||
|
(1)
|
In accordance with SEC rules, market value is based on $2.23 per share representing the closing price of our common stock on the last trading day of the year.
|
|
(2)
|
Represents an aggregate of 375,000 restricted stock units issued with respect to Mr. Horowitz's employment agreement, dated July 14, 2016, that vest in equal annual installments 125,000 shares of our common stock on July 14, 2019, July 14, 2020 and July 14, 2021, subject to Mr. Horowitz's continued employment by us (see "Executive Compensation-Narrative Disclosure to Summary Compensation Table" on pages 47-50 of this Annual Report).
|
|
(3)
|
Represents 40,000 restricted stock units granted on November 27, 2018, 50% of which will vest on November 27, 2019 and 50% of which will vest on November 27, 2020, subject to Mr. Kahn's continued employment by us.
|
|
(4)
|
Represents 50,000 restricted stock units granted on November 27, 2018, 50% of which will vest on November 27, 2019 and 50% of which will vest on November 27, 2020, subject to Mr. Greene's continued employment by us.
|
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
|
NAME AND ADDRESS
OF BENEFICIAL OWNER
|
AMOUNT AND NATURE
OF BENEFICIAL
OWNERSHIP
(1)(2)
|
PERCENTAGE OF COMMON STOCK BENEFICIALLY OWNED
(2)
|
||
|
Executive Officers and Directors
:
Corey M. Horowitz
(3)
|
7,241,454
|
29.0%
|
||
|
CMH Capital Management Corp
(4)
|
2,291,372
|
9.7%
|
||
|
Niv Harizman
(5)
|
287,424
|
1.2%
|
||
|
Emanuel Pearlman
(6)
|
130,490
|
*
|
||
|
Allison Hoffman
(7)
|
117,250
|
*
|
||
|
David C. Kahn
(8)
|
98,250
|
*
|
||
|
Jonathan E. Greene
(9)
|
93,899
|
*
|
||
|
All officers and directors as a group
(6 Persons) |
7,968,767
|
31.5%
|
||
|
5% Stockholders:
|
||||
|
Steven D. Heinemann
(10)
|
2,827,815
|
11.9%
|
||
|
Goose Hill Capital LLC
(11)
|
2,242,582
|
9.4%
|
||
|
John Herzog
(12)
|
1,200,130
|
5.1%
|
|
*
|
Less than 1%.
|
|
(1)
|
Unless otherwise indicated, we believe that all persons named in the above table have sole voting and investment power with respect to all shares of our common stock beneficially owned by them. Unless otherwise indicated the address for each listed beneficial owner is c/o Network-1 Technologies, Inc., 445 Park Avenue, Suite 912, New York, New York 10022.
|
|
(2)
|
A person is deemed to be the beneficial owner of shares of common stock that can be acquired by such person within 60 days from March 15, 2019 upon the exercise of options or restricted stock units that vest within such 60 day period. Each beneficial owner's percentage ownership is determined by assuming that all stock options and restricted stock units held by such person (but not those held by any other person) and which are exercisable or vested within 60 days from March 15, 2019 have been exercised and vested. Assumes a base of 23,747,827 shares of our common stock outstanding as of March 15, 2019.
|
|
(3)
|
Includes (i) 3,214,071 shares of common stock held by Mr. Horowitz, (ii) 1,250,000 shares of common stock subject to currently exercisable stock options held by Mr. Horowitz, (iii) 2,157,097 shares of common stock held by CMH Capital Management Corp., an entity solely owned by Mr. Horowitz, (iv) 134,275 shares of common stock owned by the CMH Capital Management Corp. Profit Sharing Plan, of which Mr. Horowitz is the trustee, (v) 67,470 shares of common stock owned by Donna Slavitt, the wife of Mr. Horowitz, (vi) an aggregate of 416,250 shares of common stock held by two trusts and a custodian account for the benefit of Mr. Horowitz's three children, and (vii) 2,291 shares of common stock held by Horowitz Partners, a general partnership of which Mr. Horowitz is a partner. Does not include 375,000 shares of common stock from restricted stock units that will not vest within 60 days of March 15, 2019.
|
|
(4)
|
Includes 2,157,097 shares of common stock owned by CMH Capital Management Corp. and 134,275 shares of common stock owned by CMH Capital Management Corp. Profit Sharing Plan. Corey M. Horowitz, by virtue of being the sole officer, director and shareholder of CMH Capital Management Corp. and the trustee of the CMH Capital Management Corp. Profit Sharing Plan, has the sole power to vote and dispose of the shares of common stock owned by CMH Capital Management Corp. and the CMH Capital Management Corp. Profit Sharing Plan.
|
|
(5)
|
Includes (i) 213,674 shares of common stock, (ii) 70,000 shares of common stock subject to currently exercisable stock options owned by Mr. Harizman and (iii) 3,750 shares of common stock subject to restricted stock units which vest within 60 days of March 15, 2019. Does not include 11,250 shares of common stock from restricted stock units that do not vest within 60 days from March 15, 2019.
|
|
(6)
|
Includes (i) 91,740 shares of common stock, (ii) 35,000 shares of common stock subject to currently exercisable stock options owned by Mr. Pearlman and (iii) 3,750 shares of common stock subject to restricted stock units which vest within 60 days of March 15, 2019. Does not include 11,250 shares of common stock from restricted stock units that do not vest within 60 days from March 15, 2019.
|
|
(7)
|
Includes (i) 43,500 shares of common stock, (ii) 70,000 shares of common stock subject to currently exercisable stock options owned by Ms. Hoffman and (iii) 3,750 shares of common stock subject to restricted stock units which vest within 60 days of March 1, 2019. Does not include 11,250 shares of common stock from restricted stock units that do not vest within 60 days from March 15, 2019.
|
|
(8)
|
Includes (i) 48,250 shares of common stock and (ii) 50,000 shares of common stock subject to currently exercisable stock options owned by Mr. Kahn. Does not include 40,000 shares of common stock from restricted stock units that do not vest within 60 days from March 15, 2019.
|
|
(9)
|
Includes (i) 43,899 shares of common stock and (ii) 50,000 shares of common stock subject to currently exercisable stock options owned by Mr. Greene. Does not include 50,000 shares of common stock from restricted stock units that do not vest within 60 days from March 15, 2019.
|
|
(10)
|
Includes 585,233 shares of common stock owned by Mr. Heinemann and 2,242,582 shares of common stock owned by Goose Hill Capital LLC. Goose Hill Capital LLC is an entity in which Mr. Heinemann is the sole member. Mr. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon an Amendment No. 7 to Schedule 13G filed by Mr. Heinemann with the SEC on February 11, 2019. The address for Mr. Heinemann is c/o Goose Hill Capital, LLC, 12378 Indian Road, North Palm Beach, Florida 33408.
|
|
(11)
|
Includes 2,242,582 shares of common stock. Steven D. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon an Amendment No. 7 to Schedule 13G filed by Mr. Heinemann with the SEC on February 11, 2019. The address for Goose Hill Capital LLC is 12378 Indian Road, North Palm Beach, Florida 33408.
|
|
(12)
|
Includes 1,200,130 shares of common stock. The aforementioned beneficial ownership is based upon a Schedule 13G filed by Mr. Herzog with the SEC on February 10, 2016. The address of Mr. Herzog is 824 Harbor Road, Southport, Connecticut 06890-1410.
|
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
|
| Index to Consolidated Financial Statements | Page |
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
Consolidated Balance Sheets as of December 31, 2018 and 2017
|
F-2
|
|
Consolidated Statements of Income and Comprehensive Income for the years ended
December 31, 2018 and 2017
|
F-3
|
|
Consolidated Statements of Changes in Stockholders' Equity for the years ended
December 31, 2018 and 2017
|
F-4
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2018 and 2017
|
F-5
|
|
Notes to Consolidated Financial Statements
|
F-6
|
|
December 31,
|
||||||||
|
2018
|
2017
|
|||||||
|
ASSETS:
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
18,680,000
|
43,351,000
|
|||||
|
Marketable securities, at fair value
|
36,311,000
|
10,804,000
|
||||||
|
Royalty receivables, net
|
444,000
|
575,000
|
||||||
|
Prepaid taxes
|
—
|
125,000
|
||||||
|
Other current assets
|
112,000
|
83,000
|
||||||
|
Total Current Assets
|
55,547,000
|
54,938,000
|
||||||
|
OTHER ASSETS:
|
||||||||
|
Deferred tax assets
|
168,000
|
168,000
|
||||||
|
Patents, net of accumulated amortization
|
1,989,000
|
2,169,000
|
||||||
|
Equity investment
|
2,541,000
|
—
|
||||||
|
Security deposits
|
21,000
|
19,000
|
||||||
|
Total Other Assets
|
4,719,000
|
2,356,000
|
||||||
|
TOTAL ASSETS
|
$
|
60,266,000
|
57,294,000
|
|||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable
|
$
|
67,000
|
244,000
|
|||||
|
Income taxes payable
|
197,000
|
—
|
||||||
|
Accrued contingency fees and related costs
|
1,136,000
|
1,780,000
|
||||||
|
Accrued payroll
|
486,000
|
709,000
|
||||||
|
Other accrued expenses
|
175,000
|
149,000
|
||||||
|
TOTAL LIABILITIES
|
2,061,000
|
2,882,000
|
||||||
|
COMMITMENTS AND CONTINGENCIES
|
||||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Preferred stock, $0.01 par value; authorized 10,000,000 shares;
none issued and outstanding at December 31, 2018 and December 31, 2017
|
—
|
—
|
||||||
|
Common stock, $0.01 par value; authorized 50,000,000 shares;
23,735,927 and 23,843,915 issued and outstanding at December 31, 2018
and December 31, 2017, respectively
|
237,000
|
238,000
|
||||||
|
Additional paid-in capital
|
65,151,000
|
64,435,000
|
||||||
|
Accumulated deficit
|
(7,102,000
|
)
|
(10,219,000
|
)
|
||||
|
Accumulated other comprehensive loss
|
(81,000
|
)
|
(42,000)
|
|||||
|
TOTAL STOCKHOLDERS' EQUITY
|
58,205,000
|
54,412,000
|
||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
60,266,000
|
$
|
57,294,000
|
||||
|
Years Ended
December 31, |
||||||||
|
2018
|
2017
|
|||||||
|
REVENUE
|
$
|
22,106,000
|
$
|
16,451,000
|
||||
|
OPERATING EXPENSES:
|
||||||||
|
Costs of revenue
|
8,072,000
|
4,970,000
|
||||||
|
Professional fees and related costs
|
1,635,000
|
2,057,000
|
||||||
|
General and administrative
|
2,255,000
|
2,255,000
|
||||||
|
Amortization of patents
|
290,000
|
206,000
|
||||||
|
Stock-based compensation
|
687,000
|
949,000
|
||||||
|
TOTAL OPERATING EXPENSES
|
12,939,000
|
10,437,000
|
||||||
|
OPERATING INCOME
|
9,167,000
|
6,014,000
|
||||||
|
OTHER INCOME:
|
||||||||
|
Interest income, net
|
876,000
|
215,000
|
||||||
|
Net realized and unrealized loss from investments
|
(29,000
|
)
|
—
|
|||||
|
Total other income
|
847,000
|
215,000
|
||||||
|
INCOME BEFORE INCOME TAXES
|
10,014,000
|
6,229,000
|
||||||
|
INCOME TAXES:
|
||||||||
|
Current
|
2,308,000
|
2,057,000
|
||||||
|
Deferred taxes, net
|
—
|
39,000
|
||||||
|
Total income taxes
|
2,308,000
|
2,096,000
|
||||||
|
NET INCOME
|
$
|
7,706,000
|
$
|
4,133,000
|
||||
|
Net Income Per Share:
|
||||||||
|
Basic
|
$
|
0.32
|
$
|
0.17
|
||||
|
Diluted
|
$
|
0.30
|
$
|
0.16
|
||||
|
Weighted average common shares outstanding:
|
||||||||
|
Basic
|
23,763,785
|
24,147,908
|
||||||
|
Diluted
|
25,354,978
|
26,396,160
|
||||||
|
Cash dividends declared per share
|
$
|
0.10
|
$
|
0.10
|
||||
|
NET INCOME
|
$
|
7,706,000
|
$
|
4,133,000
|
||||
|
OTHER COMPREHENSIVE INCOME (LOSS):
|
||||||||
|
Net unrealized holding loss on corporate bonds and notes
arising during the year, net of tax |
(39,000
|
)
|
(11,000
|
)
|
||||
|
COMPREHENSIVE INCOME
|
$
|
7,667,000
|
$
|
4,122,000
|
||||
|
Common Stock
|
Additional
Paid-in Capital |
Accumulated Deficit
|
Accumulated Other Comprehensive Income
(Loss) |
Total Stockholders' Equity
|
||||||||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||||||||
|
Balance – January 1, 2017
|
23,744,829
|
$ | 238,000 | $ | 62,367,000 | $ | (9,702,000 |
)
|
$ | (31,000 | ) | $ | 52,872,000 | |||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(2,505,000
|
)
|
―
|
(2,505,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
949,000
|
―
|
―
|
949,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
110,500
|
1,000
|
―
|
―
|
―
|
1,000
|
||||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
(13,599
|
)
|
―
|
*
|
―
|
(56,000
|
)
|
―
|
(56,000
|
)
|
||||||||||||||
|
Proceeds from exercise of options
|
250,000
|
2,000
|
335,000
|
―
|
―
|
337,000
|
||||||||||||||||||
|
Cashless exercise of options
|
50,000
|
―
|
*
|
―
|
―
|
―
|
―
|
|||||||||||||||||
|
Value of shares delivered to fund option exercise
|
(23,266
|
)
|
―
|
*
|
―
|
―
|
―
|
―
|
||||||||||||||||
|
Proceeds from exercise of warrants
|
375,000
|
4,000
|
784,000
|
―
|
―
|
788,000
|
||||||||||||||||||
|
Treasury stock purchased and retired
|
(649,549
|
)
|
(7,000
|
)
|
―
|
(2,089,000
|
)
|
―
|
(2,096,000
|
)
|
||||||||||||||
|
Net unrealized loss on corporate bonds and notes
|
―
|
―
|
―
|
―
|
(11,000
|
)
|
(11,000
|
)
|
||||||||||||||||
|
Net income
|
―
|
―
|
―
|
4,133,000
|
―
|
4,133,000
|
||||||||||||||||||
|
Balance – December 31, 2017
|
23,843,915
|
$
|
238,000
|
$
|
64,435,000
|
$
|
(10,219,000
|
)
|
$
|
(42,000
|
)
|
$
|
54,412,000
|
|||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(2,444,000
|
)
|
―
|
(2,444,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
687,000
|
―
|
―
|
687,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
490,000
|
5,000
|
―
|
―
|
―
|
5,000
|
||||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
(189,097
|
)
|
(2,000
|
)
|
―
|
(543,000
|
)
|
―
|
(545,000
|
)
|
||||||||||||||
|
Cashless exercise of options
|
144,954
|
1,000
|
―
|
―
|
―
|
1,000
|
||||||||||||||||||
|
Proceeds from exercise of options
|
25,000
|
1,000
|
29,000
|
―
|
―
|
30,000
|
||||||||||||||||||
|
Treasury stock purchased and retired
|
(578,845
|
)
|
(6,000
|
)
|
―
|
(1,602,000
|
)
|
―
|
(1,608,000
|
)
|
||||||||||||||
|
Net unrealized loss on corporate bonds and notes
|
―
|
―
|
―
|
―
|
(39,000
|
)
|
(39,000
|
)
|
||||||||||||||||
|
Net income
|
―
|
―
|
―
|
7,706,000
|
―
|
7,706,000
|
||||||||||||||||||
|
Balance – December 31, 2018
|
23,735,927
|
$
|
237,000
|
$
|
65,151,000
|
$
|
(7,102,000
|
)
|
$
|
(81,000
|
)
|
$
|
58,205,000
|
|
Years Ended
December 31, |
||||||||
|
2018
|
2017
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income
|
$
|
7,706,000
|
$
|
4,133,000
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Amortization of patents
|
290,000
|
206,000
|
||||||
|
Stock-based compensation
|
687,000
|
949,000
|
||||||
|
Deferred tax provision
|
―
|
39,000
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Royalty receivables
|
131,000
|
2,304,000
|
||||||
|
Prepaid taxes
|
125,000
|
1,070,000
|
||||||
|
Other assets
|
(31,000
|
)
|
―
|
|||||
|
Accounts payable
|
(177,000
|
)
|
73,000
|
|||||
|
Income taxes payable
|
197,000
|
―
|
||||||
|
Accrued expenses
|
(835,000
|
)
|
(2,000,000
|
)
|
||||
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
8,093,000
|
6,774,000
|
||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Development of patents
|
(110,000
|
)
|
(1,144,000
|
)
|
||||
|
Equity investment
|
(2,541,000
|
)
|
―
|
|||||
|
Purchases of marketable securities, net of sales and redemptions
|
(25,546,000
|
)
|
(9,750,000
|
)
|
||||
|
NET CASH USED IN INVESTING ACTIVITIES
|
(28,197,000
|
)
|
(10,894,000
|
)
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Cash dividends paid
|
(2,444,000
|
)
|
(2,420,000
|
)
|
||||
|
Value of shares delivered to fund withholding taxes
|
(545,000
|
)
|
(56,000
|
)
|
||||
|
Repurchases of common stock, inclusive of commissions
|
(1,608,000
|
)
|
(2,096,000
|
)
|
||||
|
Proceeds from exercises of options and warrants
|
30,000
|
1,125,000
|
||||||
|
NET CASH USED IN FINANCING ACTIVITIES
|
(4,567,000
|
)
|
(3,447,000
|
)
|
||||
|
NET (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(24,671,000
|
)
|
(7,567,000
|
)
|
||||
|
CASH AND CASH EQUIVALENTS
, beginning of year
|
43,351,000
|
50,918,000
|
||||||
|
CASH AND CASH EQUIVALENTS
, end of year
|
$
|
18,680,000
|
$
|
43,351,000
|
||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
|
Cash paid during the years for:
|
||||||||
|
Interest
|
$
|
―
|
$
|
―
|
||||
|
Income taxes
|
$
|
1,986,000
|
$
|
1,290,000
|
||||
|
NON-CASH FINANCING ACTIVITY
|
||||||||
|
Accrued dividend rights on restricted stock units
|
$
|
63,000
|
$
|
84,000
|
||||
|
[1]
|
Principles of Consolidation
|
|
[2]
|
Use of Estimates and Assumptions
|
|
[3]
|
Cash and Cash Equivalents
|
|
[4]
|
Marketable Securities
|
|
[5]
|
Equity Investments
|
|
[6]
|
Patents
|
|
[7]
|
Allowance
for Doubtful Accounts
|
|
[8]
|
Costs of Revenue
|
|
[9]
|
Income Taxes
|
|
[10]
|
Stock-Based Compensation
|
|
[11]
|
Earnings Per Share
|
|
[12]
|
Fair Value Measurements
|
|
[13]
|
Carrying Value, Recoverability and Impairment of Long-Lived Assets
|
|
[14]
|
Dividend Policy
|
|
[15]
|
Reclassification
|
|
[16]
|
New Accounting Standards
|
|
·
|
identification of the license agreement;
|
|
·
|
identification of the performance obligations in the license agreement;
|
|
·
|
determination of the consideration for the license;
|
|
·
|
allocation of the transaction price to the performance obligations in the contract; and
|
|
·
|
recognition of revenue when the Company satisfies its performance obligations.
|
| Years Ended December 31, | ||||||||
| 2018 | 2017 | |||||||
|
Fully-Paid Licenses
|
$
|
12,700,000
|
$
|
4,398,000
|
||||
|
Royalty Bearing Licenses
|
3,086,000
|
12,053,000
|
||||||
|
Other Revenue
(1)
|
6,320,000
|
—
|
||||||
|
Total Revenue
|
$
|
22,106,000
|
$
|
16,451,000
|
||||
|
2018
|
2017
|
|||||||
|
Gross carrying amount
|
$
|
7,682,000
|
$
|
7,571,000
|
||||
|
Accumulated amortization
|
(5,693,000
|
)
|
(
5,402,000
|
)
|
||||
|
Patents, net
|
$
|
1,989,000
|
$
|
2,169,000
|
||||
|
For the years ended December 31,
|
||||
|
2019
|
$
|
280,000
|
||
|
2020
|
280,000
|
|||
|
2021
|
280,000
|
|||
|
2022
|
280,000
|
|||
|
2023 and thereafter
|
869,000
|
|||
|
Total
|
$
|
1,989,000
|
||
|
2018
|
2017
|
|||||||
|
Weighted-average common shares outstanding - basic
|
23,763,785
|
24,147,908
|
||||||
|
Dilutive effect of options, warrants and restricted stock units
|
1,591,193
|
2,248,252
|
||||||
|
Weighted-average common shares outstanding - diluted
|
25,354,978
|
26,396,160
|
||||||
|
Options, restricted stock units and warrants excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive
|
―
|
―
|
||||||
|
|
2018 | 2017 | ||||||
|
Current
|
||||||||
|
State and local
|
$
|
82,000
|
$
|
45,000
|
||||
|
Federal
|
2,226,000
|
2,012,000
|
||||||
|
Total Current Tax Expense
|
$
|
2,308,000
|
$
|
2,057,000
|
||||
|
Deferred
|
||||||||
|
State and local
|
—
|
1,000
|
||||||
|
Federal
|
—
|
38,000
|
||||||
|
Total Deferred Tax Expense
|
—
|
39,000
|
||||||
|
Total Income Taxes
|
$
|
2,308,000
|
$
|
2,096,000
|
||||
|
2018
|
2017
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Options, warrants and restricted stock units
|
168,000
|
168,000
|
||||||
|
$
|
168,000
|
$
|
168,000
|
|||||
|
Years Ended
|
||||||||
|
December 31,
|
||||||||
|
2018
|
2017
|
|||||||
|
Income tax - statutory rate
|
21.00%
|
|
34.0%
|
|
||||
|
State and local, net
|
1.75%
|
|
0.73%
|
|
||||
|
Other – Net
|
0.30%
|
|
(1.08%
|
)
|
||||
|
23.05%
|
|
33.65%
|
|
|||||
|
[1]
|
Restricted Stock Units
|
|
Number of Shares
|
Weighted-Average
Grant Date Fair Value
|
|||||||
|
Balance of restricted stock units outstanding at December 31, 2017
|
820,000
|
$
|
2.28
|
|||||
|
Grants of restricted stock units
|
175,000
|
2.57
|
||||||
|
Vested restricted stock units
|
(490,000
|
)
|
2.49
|
|||||
|
Balance of unvested restricted stock units at December 31, 2018
|
505,000
|
$
|
2.17
|
|||||
|
[2]
|
Stock Options
|
|
2018
|
2017
|
|||||||||||||||
|
Weighted
|
Weighted
|
|||||||||||||||
|
Average
|
Average
|
|||||||||||||||
|
Options
|
Exercise
|
Options
|
Exercise
|
|||||||||||||
|
Outstanding
|
Price
|
Outstanding
|
Price
|
|||||||||||||
|
Options outstanding at beginning of year
|
2,010,000
|
$
|
1.28
|
2,310,000
|
$
|
1.29
|
||||||||||
|
Granted
|
―
|
―
|
―
|
―
|
||||||||||||
|
Expired
|
—
|
—
|
—
|
―
|
||||||||||||
|
Exercised
|
(375,000
|
)
|
$
|
1.74
|
(300,000
|
)
|
$
|
1.31
|
||||||||
|
Options outstanding at end of year
|
1,635,000
|
$
|
1.18
|
2,010,000
|
$
|
1.28
|
||||||||||
|
Options exercisable at end of year
|
1,635,000
|
$
|
1.18
|
2,010,000
|
$
|
1.28
|
||||||||||
|
Weighted
|
||||||||
|
Weighted
|
Average
|
|||||||
|
Range of
|
Average
|
Remaining
|
||||||
|
Exercise
|
Options
|
Exercise
|
Life in
|
Options
|
||||
|
Price
|
Outstanding
|
Price
|
Years
|
Exercisable
|
||||
|
$0.83 - $2.34
|
1,635,000
|
$1.18
|
1.49
|
1,635,000
|
||||
|
[3]
|
Warrants
|
|
2018
|
2017
|
|||||||
|
Certificates of deposit
|
$
|
13,151,000
|
$
|
2,000,000
|
||||
|
Short term bond funds
|
14,723,000
|
7,750,000
|
||||||
|
Corporate bonds and notes
|
8,437,000
|
1,054,000
|
||||||
|
Total Marketable securities
|
$
|
36,311,000
|
$
|
10,804,000
|
||||
|
[1]
|
Legal fees:
|
|
[2]
|
Patent Acquisitions:
|
|
[3]
|
Operating leases:
|
|
Payments due by period
|
||||
|
Less than 1 year
|
$
|
117,000
|
||
|
1 to 3 years
|
20,000
|
|||
|
3 to 5 years
|
—
|
|||
|
Thereafter
|
—
|
|||
|
Total
|
$
|
137,000
|
||
|
[4]
|
Savings and investment plan:
|
|
101*
|
Interactive data files: *
|
|
101.INS
|
XBRL Instance Document.
|
|
101.SCH
|
XBRL Scheme Document.
|
|
101.CAL
|
XBRL Calculation Linkbase Document.
|
|
101.DEF
|
XBRL Definition Linkbase Document.
|
|
101.LAB
|
XBRL Label Linkbase Document.
|
|
101.PRE
|
XBRL Presentation Linkbase Document.
|
|
NETWORK-1 TECHNOLOGIES, INC.
|
|||
|
|
By:
|
/s/ Corey M. Horowitz | |
| Corey M. Horowitz | |||
| Chairman and Chief Executive Officer | |||
| March 29, 2019 | |||
|
NAME
|
TITLE
|
DATE
|
||
|
/s/ Corey M. Horowitz
Corey M. Horowitz
|
Chairman and Chief Executive Officer, Chairman of the Board of Directors (principal executive officer)
|
March 29, 2019
|
||
|
/s/ David Kahn
David Kahn
|
Chief Financial Officer, Secretary and a Director (principal financial officer and principal accounting officer)
|
March 29, 2019
|
||
|
/s/ Emanuel Pearlman
Emanuel Pearlman
|
Director
|
March 29, 2019
|
||
|
/s/ Niv Harizman
Niv Harizman
|
Director
|
March 29, 2019
|
||
|
/s/ Allison Hoffman
Allison Hoffman
|
Director
|
March 29, 2019
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|